US$ 24.75
glp-1 depression Most Medications Correlated with a Lower Likelihood of Anxiety and Diagnoses GLP-1 receptor agonists attenuate depressive
Description
GLP-1 (glucagon-like peptide-1) receptor agonists are medications used primarily to treat type 2 diabetes and support weight loss
Preitner F, Ibberson M, Franklin I, et al

Severe kidney disease The gastrointestinal side effects of weight-loss injections (nausea, vomiting, diarrhoea) can cause dehydration, which can worsen existing kidney function

Mindset & Lifestyle Matter Success in weight loss is multifaceted and requires a holistic approach that goes beyond medication
doi: 10.1210/jcem-63-2-492

References Rinella, M